Open-label Extension Study of Brazikumab in Ulcerative Colitis

Condition:   Ulcerative Colitis Intervention:   Biological: Brazikumab Sponsor:   Allergan Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials